Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspective

References

• Seward ME, Swanson E, Norambuena A, et al. Amyloid-beta signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer’s disease. J Cell Sci. 2013;126(Pt 5):1278–1286.
   PubMed Web of Science ®Google Scholar
• DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):1–18.
   PubMed Web of Science ®Google Scholar
• Prince M, Wimo A, Guerchet M, et al. The global impact of dementia. World Alzheimer Rep. 2015;1–82.
   Google Scholar
• Nichols E, Szoeke CE, Vollset SE, et al. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(1):88–106.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Petersen RC, Knopman DS, et al. Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimers Dement. 2011;7(1):80–93.
   PubMed Web of Science ®Google Scholar
• Huang L-K, Chao S-P, Hu C-J. Clinical trials of new drugs for Alzheimer disease. J Biomed Sci. 2020;27(1):1–13.
   PubMed Web of Science ®Google Scholar
• Yiannopoulou KG, Papageorgiou SG. Current and future treatments in alzheimer disease: an update. J Cent Nerv Syst Dis. 2020;12:1179573520907397.
   Web of Science ®Google Scholar
• Sanabria-Castro A, Alvarado-Echeverría I, Monge-Bonilla C. Molecular pathogenesis of Alzheimer’s disease: an update. Ann Neurosci. 2017;24(1):46–54.
   PubMed Web of Science ®Google Scholar
• Van Der Kant R, Goldstein LS, Ossenkoppele R. Amyloid-β-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci. 2020;21(1):21–35.
   PubMed Web of Science ®Google Scholar
• Chen G-F, Xu T-H, Yan Y, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38(9):1205–1235.
   PubMed Web of Science ®Google Scholar
• Deng L, Haynes PA, Wu Y, et al. Amyloid-beta peptide neurotoxicity in human neuronal cells is associated with modulation of insulin-like growth factor transport, lysosomal machinery and extracellular matrix receptor interactions. Neural Regen Res. 2020;15(11):2131–2142.
   PubMed Web of Science ®Google Scholar
• Mullard A. Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating. Nat Rev Drug Discov. 2020.
   Web of Science ®Google Scholar
• Talwar P, Sinha J, Grover S, et al. Dissecting complex and multifactorial nature of Alzheimer’s disease pathogenesis: a clinical, genomic, and systems biology perspective. Mol Neurobiol. 2016;53(7):4833–4864.
   PubMed Web of Science ®Google Scholar
• Cenini G, Voos W. Mitochondria as potential targets in Alzheimer disease therapy: an update. Front Pharmacol. 2019;10:10.
   PubMed Web of Science ®Google Scholar
• Gupta VB, Chitranshi N, Den Haan J, et al. Retinal changes in Alzheimer’s disease— integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res.2020;100899.10.1016/j.preteyeres.2020.100899
   PubMedGoogle Scholar
• Mirzaei M, Gupta VB, Chick JM, et al. Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. Sci Rep. 2017;7(1):12685.
   PubMedGoogle Scholar
• Mirzaei M, Pushpitha K, Deng L, et al. Upregulation of proteolytic pathways and altered protein biosynthesis underlie retinal pathology in a mouse model of Alzheimer’s disease. Mol Neurobiol. 2019;56(9):6017–6034.
   PubMed Web of Science ®Google Scholar
• Mirzaei M, Gupta VK, Chitranshi N, et al. Retinal proteomics of experimental glaucoma model reveal intraocular pressure‐induced mediators of neurodegenerative changes. J Cell Biochem. 2020;121(12):4931–4944.
   Web of Science ®Google Scholar
• Subramaniam SR, Chesselet M-F. Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Prog Neurobiol. 2013;106:17–32.
   PubMed Web of Science ®Google Scholar
• Carmo C, Naia L, Lopes C, et al. Mitochondrial dysfunction in Huntington’s disease. Polyglutamine Disord. 2018;1049:59–83.
   Google Scholar
• Shi P, Gal J, Kwinter DM, et al. Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim Biophys Acta Mol Basis Dis. 2010;1802(1):45–51.
   Web of Science ®Google Scholar
• Gray MW. Mitochondrial evolution. Cold Spring Harb Perspect Biol. 2012;4(9):a011403.
   PubMed Web of Science ®Google Scholar
• McCarron JG, Wilson C, Sandison ME, et al. From structure to function: mitochondrial morphology, motion and shaping in vascular smooth muscle. J Vasc Res. 2013;50(5):357–371.
   PubMed Web of Science ®Google Scholar
• Kühlbrandt W. Structure and function of mitochondrial membrane protein complexes. BMC Biol. 2015;13(1):1–11.
   PubMedGoogle Scholar
• Garrido C, Galluzzi L, Brunet M, et al. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 2006;13(9):1423–1433.
   PubMed Web of Science ®Google Scholar
• Kruse R, Sahebekhtiari N, Højlund K. The mitochondrial proteomic signatures of human skeletal muscle linked to insulin resistance. Int J Mol Sci. 2020;21(15):5374.
   Web of Science ®Google Scholar
• Johannsen DL, Ravussin E. The role of mitochondria in health and disease. Curr Opin Pharmacol. 2009;9(6):780–786.
   PubMed Web of Science ®Google Scholar
• Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145–1159.
   PubMed Web of Science ®Google Scholar
• Rango M, Bresolin N. Brain mitochondria, aging, and Parkinson’s disease. Genes (Basel). 2018;9(5):250.
   Web of Science ®Google Scholar
• Fecher C, Trovò L, Müller SA, et al. Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity. Nat Neurosci. 2019;22(10):1731–1742.
   PubMed Web of Science ®Google Scholar
• Friede RL. Enzyme histochemical studies of senile plaques. J Neuropathol Exp Neurol. 1965;24(3):477–491.
   Web of Science ®Google Scholar
• Swerdlow RH, Kish SJ. Mitochondria in Alzheimer’s disease. Int Rev Neurobiol. 2002;53:341–385.
   PubMed Web of Science ®Google Scholar
• Hirai K, Aliev G, Nunomura A, et al. Mitochondrial abnormalities in Alzheimer’s disease. J Neurosci. 2001;21(9):3017–3023.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhao F, Ma X, et al. Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances. Mol Neurodegener. 2020;15:1–22.
   PubMed Web of Science ®Google Scholar
• Hauptmann S, Scherping I, Dröse S, et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging. 2009;30(10):1574–1586.
   PubMed Web of Science ®Google Scholar
• Fang X, Lee CS. Proteome characterization of mouse brain mitochondria using electrospray ionization tandem mass spectrometry. Methods Enzymol. 2009;457:49–62.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang X. Comparative mitochondrial proteomics: perspective in human diseases. J Hematol Oncol. 2012;5(1):11.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Palmieri EM, Castegna A. Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Rev Proteomics. 2016;13(3):259–274.
   PubMed Web of Science ®Google Scholar
• Song J, Herrmann JM, Becker T. Quality control of the mitochondrial proteome. Nat Rev Mol Cell Biol. 2020;21(1):1–17.
   PubMedGoogle Scholar
• Endo T, Yamano K, Kawano S. Structural insight into the mitochondrial protein import system. Biochimi Biophys Acta (BBA) Biomembr. 2011;1808(3):955–970.
   PubMed Web of Science ®Google Scholar
• Couvillion MT, Soto IC, Shipkovenska G, et al. Synchronized mitochondrial and cytosolic translation programs. Nature. 2016;533(7604):499–503.
   PubMed Web of Science ®Google Scholar
• Kawahara M, Ohtsuka I, Yokoyama S, et al. Membrane incorporation, channel formation, and disruption of calcium Homeostasis by Alzheimer’s β Amyloid protein. Int J Alzheimer’s Dis. 2011;2011:1–17. [ 2011].
   Google Scholar
• Han XJ, Hu YY, Yang ZJ, et al. Amyloid β-42 induces neuronal apoptosis by targeting mitochondria. Mol Med Rep. 2017;16(4):4521–4528.
   PubMed Web of Science ®Google Scholar
• Petersen CAH, Alikhani N, Behbahani H, et al. The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Nat Acad Sci. 2008;105(35):13145–13150.
   PubMed Web of Science ®Google Scholar
• Pinho CM, Teixeira PF, Glaser E. Mitochondrial import and degradation of amyloid-β peptide. Biochimica et Biophysica Acta (BBA)-Bioenergetics. 2014;1837(7):1069–1074.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Xiong S, Markesbery WR, et al. Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide. Neurochem Res. 2005;30(1):113–122.
   PubMed Web of Science ®Google Scholar
• David DC, Hauptmann S, Scherping I, et al. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem. 2005;280(25):23802–23814.
   PubMed Web of Science ®Google Scholar
• Chou JL, Shenoy DV, Thomas N, et al. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer’s disease. J Proteomics. 2011;74(4):466–479.
   PubMed Web of Science ®Google Scholar
• Chakroborty S, Kim J, Schneider C, et al. Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer’s disease mice. J Neurosci. 2012;32(24):8341–8353.
   PubMed Web of Science ®Google Scholar
• Supnet C, Bezprozvanny I. Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer’s disease. J Alzheimers Dis. 2010;20(s2):S487–S498.
   PubMedGoogle Scholar
• Keinan N, Pahima H, Ben-Hail D, et al. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis. Biochim Biophys Acta-Mol Cell Res. 2013;1833(7):1745–1754.
   PubMed Web of Science ®Google Scholar
• Magi S, Castaldo P, Macrì ML, et al. Intracellular calcium dysregulation: implications for Alzheimer’s disease. Biomed Res Int. 2016 2016;2016: 1–14.
   PubMed Web of Science ®Google Scholar
• Kadowaki H, Nishitoh H, Urano F, et al. Amyloid β induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ. 2005;12(1):19–24.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li T, Li P, et al. The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer’s disease. Oxid Med Cell Longev. 2015 2015;2015: 1–12.
   Web of Science ®Google Scholar
• Cheignon C, Tomas M, Bonnefont-Rousselot D, et al. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol. 2018;14:450–464.
   PubMed Web of Science ®Google Scholar
• Guo C, Sun L, Chen X, et al. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2013;8(21):2003.
   PubMed Web of Science ®Google Scholar
• Shen L, Yang A, Chen X, et al. Proteomic profiling of cerebrum mitochondria, myelin sheath, and synaptosome revealed mitochondrial damage and synaptic impairments in association with 3× Tg‐AD mice model. Cell Mol Neurobiol. 2021;41(1):1–19.
   PubMedGoogle Scholar
• Cui J, Wang L, Ren X, et al. LRPPRC: a multifunctional protein involved in energy metabolism and human disease. Front Physiol. 2019;10:595.
   PubMed Web of Science ®Google Scholar
• Li KW, Ganz AB, Smit AB. Proteomics of neurodegenerative diseases: analysis of human post-mortem brain. J Neurochem. 2019;151(4):435–445.
   PubMed Web of Science ®Google Scholar
• Signorile A, Sgaramella G, Bellomo F, et al. Prohibitins: a critical role in mitochondrial functions and implication in diseases. Cells. 2019;8(1):71.
   Web of Science ®Google Scholar
• Zhou P, Qian L, D’Aurelio M, et al. Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities. J Neurosci. 2012;32(2):583–592.
   PubMed Web of Science ®Google Scholar
• Lachen-Montes M, González-Morales A, Palomino M, et al. Early-onset molecular derangements in the olfactory bulb of Tg2576 mice: novel insights into the stress-responsive olfactory kinase dynamics in Alzheimer’s disease. Front Aging Neurosci. 2019;11:141.
   PubMed Web of Science ®Google Scholar
• Lachén-Montes M, González-Morales A, Zelaya MV, et al. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer’s disease progression. Sci Rep. 2017;7(1):1–15.
   PubMedGoogle Scholar
• Merkwirth C, Martinelli P, Korwitz A, et al. Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration. PLoS Genet. 2012;8(11):e1003021.
   PubMed Web of Science ®Google Scholar
• Rhein V, Song X, Wiesner A, et al. Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice. Proc Nat Acad Sci. 2009;106(47):20057–20062.
   PubMed Web of Science ®Google Scholar
• Thygesen C, Metaxas A, Larsen MR, et al. Age-dependent changes in the sarkosyl-insoluble proteome of APP SWE/PS1 ΔE9 transgenic mice implicate dysfunctional mitochondria in the pathogenesis of Alzheimer’s disease. J Alzheimers Dis. 2018;64(4):1247–1259.
   PubMed Web of Science ®Google Scholar
• Walls KC, Coskun P, Gallegos-Perez JL, et al. Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid. J Biol Chem. 2012;287(36):30317–30327.
   PubMed Web of Science ®Google Scholar
• Mangione MR, Vilasi S, Marino C, et al. Hsp60, amateur chaperone in amyloid-beta fibrillogenesis. Biochim Biophys Acta. 2016;1860(11):2474–2483.
   PubMed Web of Science ®Google Scholar
• Yu H, Lin X, Wang D, et al. Mitochondrial molecular abnormalities revealed by proteomic analysis of hippocampal organelles of mice triple transgenic for Alzheimer disease. Front Mol Neurosci. 2018;11:74.
   PubMed Web of Science ®Google Scholar
• Roy M, Reddy PH, Iijima M, et al. Mitochondrial division and fusion in metabolism. Curr Opin Cell Biol. 2015;33:111–118.
   PubMed Web of Science ®Google Scholar
• Shirendeb UP, Calkins MJ, Manczak M, et al. Mutant huntingtin’s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington’s disease. Hum Mol Genet. 2012;21(2):406–420.
   PubMed Web of Science ®Google Scholar
• Manczak M, Reddy PH. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer’s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet. 2012;21(11):2538–2547.
   PubMed Web of Science ®Google Scholar
• Kücükköse C, Taskin AA, Marada A, et al. Functional coupling of presequence processing and degradation in human mitochondria. FEBS J. 2020;288(2):600–613.
   PubMed Web of Science ®Google Scholar
• Mossmann D, Vögtle F-N, Taskin AA, et al. Amyloid-β peptide induces mitochondrial dysfunction by inhibition of preprotein maturation. Cell Metab. 2014;20(4):662–669.
   PubMed Web of Science ®Google Scholar
• Lynn BC, Wang J, Markesbery WR, et al. Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer’s disease. J Alzheimers Dis. 2010;19(1):325–339.
   PubMed Web of Science ®Google Scholar
• Gillardon F, Rist W, Kussmaul L, et al. Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition. Proteomics. 2007;7(4):605–616.
   PubMed Web of Science ®Google Scholar
• Stroud DA, Formosa LE, Wijeyeratne XW, et al. Gene knockout using transcription activator-like effector nucleases (TALENs) reveals that human NDUFA9 protein is essential for stabilizing the junction between membrane and matrix arms of complex I. J Biol Chem. 2013;288(3):1685–1690.
   PubMed Web of Science ®Google Scholar
• Adav SS, Park JE, Sze SK. Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease. Mol Brain. 2019;12(1):1–12.
   PubMedGoogle Scholar
• Du X, Shi Q, Zhao Y, et al. Se-methylselenocysteine (smc) improves cognitive deficits by attenuating synaptic and metabolic abnormalities in Alzheimer’s mice model: a proteomic study. ACS Chem Neurosci. 2021;12(7):1112–1132.
   Web of Science ®Google Scholar
• Lloret A, Esteve D, Lloret M-A, et al. When does Alzheimer′ s disease really start? The role of biomarkers. Int J Mol Sci. 2019;20(22):5536.
   Web of Science ®Google Scholar
• Beason-Held LL, Goh JO, An Y, et al. Changes in brain function occur years before the onset of cognitive impairment. J Neurosci. 2013;33(46):18008–18014.
   PubMed Web of Science ®Google Scholar
• Dubois B, Hampel H, Feldman HH, et al. Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292–323.
   PubMed Web of Science ®Google Scholar
• Dey KK, Wang H, Niu M, et al. Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease. Clin Proteomics. 2019;16(1):1–12.
   PubMedGoogle Scholar
• Wang H, Dey KK, Chen P-C, et al. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease. Mol Neurodegener. 2020;15(1):1–20.
   PubMed Web of Science ®Google Scholar
• Bader JM, Geyer PE, Müller JB, et al. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer’s disease. Mol Syst Biol. 2020;16(6):e9356.
   PubMed Web of Science ®Google Scholar
• Yin J, Reiman EM, Beach TG, et al. Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology. 2020;94(23):e2404–e2411.
   PubMed Web of Science ®Google Scholar
• Abyadeh M, Djafarian K, Heydarinejad F, et al. Association between apolipoprotein E Gene polymorphism and Alzheimer’s disease in an iranian population: a meta-analysis. J Mol Neurosci. 2019;69(4):557–562.
   PubMed Web of Science ®Google Scholar
• Hesse R, Hurtado ML, Jackson RJ, et al. Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype. Acta Neuropathol Commun. 2019;7(1):1–18.
   PubMed Web of Science ®Google Scholar
• Deng L, Gupta VK, Wu Y, et al. Mouse model of Alzheimer’s disease demonstrates differential effects of early disease pathology on various brain regions. Proteomics. 2021;21(7–8):2000213.
   Web of Science ®Google Scholar
• He K, Nie L, Zhou Q, et al. Proteomic Profiles of the Early Mitochondrial Changes in APP/PS1 and ApoE4 Transgenic Mice Models of Alzheimer’s Disease. J Proteome Res • This study showed the significant effect of APOE polymorphism on AD-related mitochondrial proteome changes.. 2019;18(6):2632–2642.
   Google Scholar
• Beam CR, Kaneshiro C, Jang JY, et al. Differences between women and men in incidence rates of dementia and Alzheimer’s disease. J Alzheimers Dis. 2018;64(4):1077–1083.
   PubMed Web of Science ®Google Scholar
• De Leeuw F, De Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The rotterdam scan study. J Neurol Neurosurg. 2001;70(1):9–14.
   PubMed Web of Science ®Google Scholar
• Van Den Heuvel D, Admiraal-Behloul F, Ten Dam V, et al. Different progression rates for deep white matter hyperintensities in elderly men and women. Neurology. 2004;63(9):1699–1701.
   PubMed Web of Science ®Google Scholar
• Mortensen E, Høgh P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology. 2001;57(1):89–95.
   PubMed Web of Science ®Google Scholar
• Shi L, Du X, Zhou H, et al. Cumulative effects of the ApoE genotype and gender on the synaptic proteome and oxidative stress in the mouse brain. Int J Neuropsychopharmacol. 2014;17(11):1863–1879.
   PubMed Web of Science ®Google Scholar
• Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer’s disease-lessons from pathology. BMC Med. 2014;12(1):1–12.
   Google Scholar
• Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2011;42(9):2672–2713.
   PubMed Web of Science ®Google Scholar
• Qiu C, Xu W, Winblad B, et al. Vascular risk profiles for dementia and Alzheimer’s disease in very old people: a population-based longitudinal study. J Alzheimers Dis. 2010;20(1):293–300.
   PubMed Web of Science ®Google Scholar
• Gallart-Palau X, Lee BS, Adav SS, et al. Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer’s disease with cerebrovascular disease. Mol Brain. 2016;9(1):1–15.
   PubMedGoogle Scholar
• Alfadhel M, Nashabat M, Ali QA, et al. Mitochondrial iron-sulfur cluster biogenesis from molecular understanding to clinical disease. Neurosciences. 2017;22(1):4.
   PubMed Web of Science ®Google Scholar
• Wang X, Li M, Peng L, et al. SOD2 promotes the expression of ABCC2 through lncRNA CLCA3p and improves the detoxification capability of liver cells. Toxicol Lett. 2020;327:9–18.
   PubMed Web of Science ®Google Scholar
• Dhamad AE, Greene E, Sales M, et al. 75-kDa glucose-regulated protein (GRP75) is a novel molecular signature for heat stress response in avian species. Am J Physiol Cell Physiol. 2020;318(2):C289–C303.
   PubMed Web of Science ®Google Scholar
• Lalaouna D, Baude J, Wu Z, et al. RsaC sRNA modulates the oxidative stress response of Staphylococcus aureus during manganese starvation. Nucleic Acids Res. 2019;47(18):9871–9887.
   PubMed Web of Science ®Google Scholar
• Weidling I, Swerdlow RH. Mitochondrial dysfunction and stress responses in alzheimer’s disease. Biology (Basel). 2019;8(2):39.
   Google Scholar
• Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.
   PubMed Web of Science ®Google Scholar
• Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947–1951.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Furumichi M, Sato Y, et al. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545–D551.
   PubMed Web of Science ®Google Scholar